Detalhe da pesquisa
1.
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Lancet Oncol
; 24(1): 91-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36436516
2.
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.
Cancer
; 129(6): 946-955, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601958
3.
Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer.
Int J Mol Sci
; 22(12)2021 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198491
4.
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.
Hered Cancer Clin Pract
; 18: 1, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31956380
5.
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Int J Cancer
; 144(5): 1195-1204, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30175445
6.
Functional characterization of novel germline TP53 variants in Swedish families.
Clin Genet
; 96(3): 216-225, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081129
7.
Proteomic Profiling of Diffuse Large B-Cell Lymphomas.
Pathobiology
; 85(4): 211-219, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617697
8.
Investigation of Genetic Alterations Associated With Interval Breast Cancer.
JAMA Oncol
; 10(3): 372-379, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270937
9.
Prediction of breast cancer risk for sisters of women attending screening.
J Natl Cancer Inst
; 115(11): 1310-1317, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243694
10.
Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies.
Cancers (Basel)
; 14(19)2022 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230587
11.
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).
Cancers (Basel)
; 14(2)2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053544
12.
Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer.
Biomedicines
; 10(5)2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625741
13.
Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
Eur J Med Genet
; 64(12): 104350, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606975
14.
Germline TP53 Testing in Breast Cancers: Why, When and How?
Cancers (Basel)
; 12(12)2020 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327514
15.
Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.
Eur J Hum Genet
; 28(10): 1379-1386, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457520
16.
Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives.
Eur J Hum Genet
; 32(1): 6-7, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474788
17.
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.
J Ovarian Res
; 9(1): 27, 2016 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179933
18.
Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells.
Oncotarget
; 7(24): 35703-35723, 2016 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27248168